#151873

Anti-SPRED1 [M23-P2G3]

Cat. #151873

Anti-SPRED1 [M23-P2G3]

Cat. #: 151873

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Sprouty-Related, EVH1 Domain Containing 1 (SPRED1)

Class: Monoclonal

Application: ELISA ; IF ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ayham Alnabulsi

Institute: Vertebrate Antibodies Limited

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-SPRED1 [M23-P2G3]
  • Research fields: Cancer;Cell signaling and signal transduction
  • Clone: M23P2G3
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IF ; WB
  • Description: Sprouty-Related, EVH1 Domain Containing 1 (SPRED1) is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. SPRED1 can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in SPRED1 can cause neurofibromatosis type 1-like syndrome (NFLS) and contribute to Legius syndrome and childhood leukemia.
  • Immunogen: Peptide Sequence YVPLRMCHR (amino acids 420 428)
  • Isotype: IgG1 kappa
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: ELISA- Peptide immunogenWestern Blot- Hela whole cell extractImmunofluorescence- Hela Cells

Target Details

  • Target: Sprouty-Related, EVH1 Domain Containing 1 (SPRED1)
  • Tissue cell line specificity: ELISA- Peptide immunogenWestern Blot- Hela whole cell extractImmunofluorescence- Hela Cells
  • Target background: Sprouty-Related, EVH1 Domain Containing 1 (SPRED1) is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. SPRED1 can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in SPRED1 can cause neurofibromatosis type 1-like syndrome (NFLS) and contribute to Legius syndrome and childhood leukemia.

Applications

  • Application: ELISA ; IF ; WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -20° C
  • Shipping conditions: Shipping at 4° C